Amphetamine treatment increases corticotropin-releasing factor receptors in the dorsal raphe nucleus

Ronald B. Pringle, Nicholas J. Mouw, Jodi L. Lukkes, Gina L Forster

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Psychostimulant use increases anxious behavior, likely through interactions between central corticotropin-releasing factor (CRF) and serotonergic systems. The current study examined whether chronic amphetamine treatment (2.5 mg/kg, 14 days) or withdrawal altered CRF receptor densities in the serotonergic dorsal raphe nucleus (dRN). Amphetamine treatment increased CRF2 receptor densities in most subregions of the dRN, and CRF2 receptors were still elevated following 6 weeks of withdrawal. No changes in CRF1 receptor densities were observed following amphetamine treatment or during withdrawal. Selective increases in dRN CRF2 receptors may be related to increased anxiety-like behaviors following psychostimulant use.

Original languageEnglish (US)
Pages (from-to)62-65
Number of pages4
JournalNeuroscience Research
Volume62
Issue number1
DOIs
StatePublished - Sep 1 2008

Fingerprint

Corticotropin-Releasing Hormone Receptors
Amphetamine
Corticotropin-Releasing Hormone
Anxiety
Dorsal Raphe Nucleus
CRF receptor type 2

Keywords

  • Amphetamine
  • Anxiety
  • CRF
  • Dorsal raphe nucleus
  • Rat
  • Serotonin

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Amphetamine treatment increases corticotropin-releasing factor receptors in the dorsal raphe nucleus. / Pringle, Ronald B.; Mouw, Nicholas J.; Lukkes, Jodi L.; Forster, Gina L.

In: Neuroscience Research, Vol. 62, No. 1, 01.09.2008, p. 62-65.

Research output: Contribution to journalArticle

Pringle, Ronald B. ; Mouw, Nicholas J. ; Lukkes, Jodi L. ; Forster, Gina L. / Amphetamine treatment increases corticotropin-releasing factor receptors in the dorsal raphe nucleus. In: Neuroscience Research. 2008 ; Vol. 62, No. 1. pp. 62-65.
@article{909ef9b4f8024c09962124a0ef88046a,
title = "Amphetamine treatment increases corticotropin-releasing factor receptors in the dorsal raphe nucleus",
abstract = "Psychostimulant use increases anxious behavior, likely through interactions between central corticotropin-releasing factor (CRF) and serotonergic systems. The current study examined whether chronic amphetamine treatment (2.5 mg/kg, 14 days) or withdrawal altered CRF receptor densities in the serotonergic dorsal raphe nucleus (dRN). Amphetamine treatment increased CRF2 receptor densities in most subregions of the dRN, and CRF2 receptors were still elevated following 6 weeks of withdrawal. No changes in CRF1 receptor densities were observed following amphetamine treatment or during withdrawal. Selective increases in dRN CRF2 receptors may be related to increased anxiety-like behaviors following psychostimulant use.",
keywords = "Amphetamine, Anxiety, CRF, Dorsal raphe nucleus, Rat, Serotonin",
author = "Pringle, {Ronald B.} and Mouw, {Nicholas J.} and Lukkes, {Jodi L.} and Forster, {Gina L}",
year = "2008",
month = "9",
day = "1",
doi = "10.1016/j.neures.2008.05.009",
language = "English (US)",
volume = "62",
pages = "62--65",
journal = "Neuroscience Research",
issn = "0168-0102",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Amphetamine treatment increases corticotropin-releasing factor receptors in the dorsal raphe nucleus

AU - Pringle, Ronald B.

AU - Mouw, Nicholas J.

AU - Lukkes, Jodi L.

AU - Forster, Gina L

PY - 2008/9/1

Y1 - 2008/9/1

N2 - Psychostimulant use increases anxious behavior, likely through interactions between central corticotropin-releasing factor (CRF) and serotonergic systems. The current study examined whether chronic amphetamine treatment (2.5 mg/kg, 14 days) or withdrawal altered CRF receptor densities in the serotonergic dorsal raphe nucleus (dRN). Amphetamine treatment increased CRF2 receptor densities in most subregions of the dRN, and CRF2 receptors were still elevated following 6 weeks of withdrawal. No changes in CRF1 receptor densities were observed following amphetamine treatment or during withdrawal. Selective increases in dRN CRF2 receptors may be related to increased anxiety-like behaviors following psychostimulant use.

AB - Psychostimulant use increases anxious behavior, likely through interactions between central corticotropin-releasing factor (CRF) and serotonergic systems. The current study examined whether chronic amphetamine treatment (2.5 mg/kg, 14 days) or withdrawal altered CRF receptor densities in the serotonergic dorsal raphe nucleus (dRN). Amphetamine treatment increased CRF2 receptor densities in most subregions of the dRN, and CRF2 receptors were still elevated following 6 weeks of withdrawal. No changes in CRF1 receptor densities were observed following amphetamine treatment or during withdrawal. Selective increases in dRN CRF2 receptors may be related to increased anxiety-like behaviors following psychostimulant use.

KW - Amphetamine

KW - Anxiety

KW - CRF

KW - Dorsal raphe nucleus

KW - Rat

KW - Serotonin

UR - http://www.scopus.com/inward/record.url?scp=48049113459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48049113459&partnerID=8YFLogxK

U2 - 10.1016/j.neures.2008.05.009

DO - 10.1016/j.neures.2008.05.009

M3 - Article

VL - 62

SP - 62

EP - 65

JO - Neuroscience Research

JF - Neuroscience Research

SN - 0168-0102

IS - 1

ER -